Ekso Bionics Holdings Stock Probability of Future Stock Price Finishing Under 0.01

EKSO Stock  USD 0.70  0.04  6.06%   
Ekso Bionics' future price is the expected price of Ekso Bionics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Ekso Bionics Holdings performance during a given time horizon utilizing its historical volatility. Check out Ekso Bionics Backtesting, Ekso Bionics Valuation, Ekso Bionics Correlation, Ekso Bionics Hype Analysis, Ekso Bionics Volatility, Ekso Bionics History as well as Ekso Bionics Performance.
  
As of the 2nd of December 2024, Price To Sales Ratio is likely to drop to 1.80. In addition to that, Price Earnings Ratio is likely to drop to -2.4. Please specify Ekso Bionics' target price for which you would like Ekso Bionics odds to be computed.

Ekso Bionics Target Price Odds to finish below 0.01

The tendency of Ekso Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to $ 0.01  or more in 90 days
 0.70 90 days 0.01 
near 1
Based on a normal probability distribution, the odds of Ekso Bionics to drop to $ 0.01  or more in 90 days from now is near 1 (This Ekso Bionics Holdings probability density function shows the probability of Ekso Stock to fall within a particular range of prices over 90 days) . Probability of Ekso Bionics Holdings price to stay between $ 0.01  and its current price of $0.7 at the end of the 90-day period is nearly 4.77 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.55 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Ekso Bionics will likely underperform. Additionally Ekso Bionics Holdings has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Ekso Bionics Price Density   
       Price  

Predictive Modules for Ekso Bionics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ekso Bionics Holdings. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ekso Bionics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.030.674.43
Details
Intrinsic
Valuation
LowRealHigh
0.142.776.53
Details
Naive
Forecast
LowNextHigh
0.020.764.53
Details
2 Analysts
Consensus
LowTargetHigh
8.199.009.99
Details

Ekso Bionics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Ekso Bionics is not an exception. The market had few large corrections towards the Ekso Bionics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ekso Bionics Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ekso Bionics within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.81
β
Beta against Dow Jones1.55
σ
Overall volatility
0.18
Ir
Information ratio -0.19

Ekso Bionics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ekso Bionics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ekso Bionics Holdings can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Ekso Bionics generated a negative expected return over the last 90 days
Ekso Bionics has some characteristics of a very speculative penny stock
Ekso Bionics has high historical volatility and very poor performance
Ekso Bionics has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 18.28 M. Net Loss for the year was (15.2 M) with profit before overhead, payroll, taxes, and interest of 6.75 M.
Ekso Bionics Holdings currently holds about 31.91 M in cash with (12.05 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Ekso Bionics has a frail financial position based on the latest SEC disclosures
Latest headline from thelincolnianonline.com: Ekso Bionics Earns Hold Rating from Analysts at StockNews.com

Ekso Bionics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ekso Stock often depends not only on the future outlook of the current and potential Ekso Bionics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ekso Bionics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding13.9 M
Cash And Short Term Investments8.6 M

Ekso Bionics Technical Analysis

Ekso Bionics' future price can be derived by breaking down and analyzing its technical indicators over time. Ekso Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Ekso Bionics Holdings. In general, you should focus on analyzing Ekso Stock price patterns and their correlations with different microeconomic environments and drivers.

Ekso Bionics Predictive Forecast Models

Ekso Bionics' time-series forecasting models is one of many Ekso Bionics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Ekso Bionics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Ekso Bionics Holdings

Checking the ongoing alerts about Ekso Bionics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Ekso Bionics Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Ekso Bionics generated a negative expected return over the last 90 days
Ekso Bionics has some characteristics of a very speculative penny stock
Ekso Bionics has high historical volatility and very poor performance
Ekso Bionics has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 18.28 M. Net Loss for the year was (15.2 M) with profit before overhead, payroll, taxes, and interest of 6.75 M.
Ekso Bionics Holdings currently holds about 31.91 M in cash with (12.05 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Ekso Bionics has a frail financial position based on the latest SEC disclosures
Latest headline from thelincolnianonline.com: Ekso Bionics Earns Hold Rating from Analysts at StockNews.com
When determining whether Ekso Bionics Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ekso Bionics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ekso Bionics Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ekso Bionics Holdings Stock:
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ekso Bionics. If investors know Ekso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ekso Bionics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.64)
Revenue Per Share
1.004
Quarterly Revenue Growth
(0.10)
Return On Assets
(0.24)
Return On Equity
(0.74)
The market value of Ekso Bionics Holdings is measured differently than its book value, which is the value of Ekso that is recorded on the company's balance sheet. Investors also form their own opinion of Ekso Bionics' value that differs from its market value or its book value, called intrinsic value, which is Ekso Bionics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ekso Bionics' market value can be influenced by many factors that don't directly affect Ekso Bionics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ekso Bionics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ekso Bionics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ekso Bionics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.